Literature DB >> 15710469

Blood-brain barrier disruption and lesion localisation in experimental autoimmune encephalomyelitis with predominant cerebellar and brainstem involvement.

Diane M Muller1, Michael P Pender, Judith M Greer.   

Abstract

The role of the blood-brain barrier (BBB) in determining lesion distribution was assessed in an atypical model of experimental autoimmune encephalomyelitis (EAE) induced in C3H/HeJ mice by immunisation with peptide 190-209 of myelin proteolipid protein, which can result in two distinct types of EAE, each with distinct lesion distribution. Areas of the BBB showing constitutively greater permeability in naive mice did not correlate with the lesion distribution in EAE. BBB disruption occurred only in sites of inflammatory cell infiltration. Irrespective of the clinical type, the BBB was disrupted in the cerebellum and brainstem. Pertussis toxin had no effect on lesion distribution. Thus, lesion distribution is not influenced solely by BBB permeability.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15710469     DOI： 10.1016/j.jneuroim.2004.11.011

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN： 0165-5728            Impact factor:   3.478


  22 in total

1.  Subcortical brain atrophy in Gulf War Illness.

Authors:  Peka Christova; Lisa M James; Brian E Engdahl; Scott M Lewis; Adam F Carpenter; Apostolos P Georgopoulos
Journal:  Exp Brain Res       Date:  2017-06-20       Impact factor: 1.972

Review 2.  Failed central nervous system regeneration: a downside of immune privilege?

Authors:  Ingo Bechmann
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 3.  CNS drug delivery: opioid peptides and the blood-brain barrier.

Authors:  Ken A Witt; Thomas P Davis
Journal:  AAPS J       Date:  2006-02-24       Impact factor: 4.009

4.  Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design.

Authors:  Mitchell R Emerson; Ryan J Gallagher; Janet G Marquis; Steven M LeVine
Journal:  Comp Med       Date:  2009-04       Impact factor: 0.982

5.  Intrinsic and induced regulation of the age-associated onset of spontaneous experimental autoimmune encephalomyelitis.

Authors:  Hong Zhang; Joseph R Podojil; Xunrong Luo; Stephen D Miller
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 6.  Nanoparticle transport across the blood brain barrier.

Authors:  Andreas M Grabrucker; Barbara Ruozi; Daniela Belletti; Francesca Pederzoli; Flavio Forni; Maria Angela Vandelli; Giovanni Tosi
Journal:  Tissue Barriers       Date:  2016-02-25

7.  Site-specific chemokine expression regulates central nervous system inflammation and determines clinical phenotype in autoimmune encephalomyelitis.

Authors:  Joshua S Stoolman; Patrick C Duncker; Amanda K Huber; Benjamin M Segal
Journal:  J Immunol       Date:  2014-06-13       Impact factor: 5.422

8.  Peripheral and central neuronal ATF3 precedes CD4+ T-cell infiltration in EAE.

Authors:  Noémie Frezel; Fabien Sohet; Richard Daneman; Allan I Basbaum; Joao M Braz
Journal:  Exp Neurol       Date:  2016-06-23       Impact factor: 5.330

9.  Nanoparticle-based evaluation of blood-brain barrier leakage during the foreign body response.

Authors:  Andrew J Sawyer; Themis R Kyriakides
Journal:  J Neural Eng       Date:  2013-01-21       Impact factor: 5.379

10.  Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells.

Authors:  Bernadette Pöllinger; Gurumoorthy Krishnamoorthy; Kerstin Berer; Hans Lassmann; Michael R Bösl; Robert Dunn; Helena S Domingues; Andreas Holz; Florian C Kurschus; Hartmut Wekerle
Journal:  J Exp Med       Date:  2009-06-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.